Amanote Research
Register
Sign In
Effect of Cyp2d6 Genetic Polymorphism on the Pharmacokinetics of Multiple-Dose Metoclopramide
Clinical Therapeutics
- United States
doi 10.1016/j.clinthera.2015.05.173
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pharmacology
Date
August 1, 2015
Authors
J.Y. Byeon
S.H. Kim
Y.H. Kim
H.J. Lee
Y. Lee
Y.J. Lee
D.H. Kim
H.J. Lim
C.G. Jang
S.Y. Lee
Publisher
Elsevier BV
Related search
Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
Clinical Pharmacokinetics
Pharmacology
The Relationship Between Clinical Pharmacokinetics of Aripiprazole and CYP2D6 Genetic Polymorphism: Effects of CYP Enzyme Inhibition by Coadministration of Paroxetine or Fluvoxamine
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Effect of Organic Cation Transporter Genetic Polymorphism on Ethambutol Pharmacokinetics Using Physiologically Based Pharmacokinetic (PBPK) Model
Clinical Therapeutics
Pharmacology
Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Multiple-Dose Pharmacokinetics of Amdinocillin in Healthy Volunteers.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Dystonic Reactions and the Pharmacokinetics of Metoclopramide in Children.
British Journal of Clinical Pharmacology
Pharmacology
Effect of Antacids and Ranitidine on the Single-Dose Pharmacokinetics of Fosamprenavir
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Impact of CYP2D6*10 Polymorphism on the Pharmacokinetics of Mirtazapine and Its Desmethylated Metabolite in Japanese Psychiatric Patients Treated With Mirtazapine
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
Effects ofFlos Carthamion CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
